147 related articles for article (PubMed ID: 30889860)
1. Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO-1) Inhibitors Based on
Zhao H; Sun P; Guo W; Wang Y; Zhang A; Meng L; Ding C
Molecules; 2019 Mar; 24(6):. PubMed ID: 30889860
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Kumar S; Malachowski WP; DuHadaway JB; LaLonde JM; Carroll PJ; Jaller D; Metz R; Prendergast GC; Muller AJ
J Med Chem; 2008 Mar; 51(6):1706-18. PubMed ID: 18318466
[TBL] [Abstract][Full Text] [Related]
3. The first indoleamine-2,3-dioxygenase-1 (IDO1) inhibitors containing carborane.
Austin CJ; Kahlert J; Issa F; Reed JH; Smith JR; Ioppolo JA; Ong JA; Jamie JF; Hibbs D; Rendina LM
Dalton Trans; 2014 Jul; 43(28):10719-24. PubMed ID: 24752804
[TBL] [Abstract][Full Text] [Related]
4. Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
Cheng MF; Hung MS; Song JS; Lin SY; Liao FY; Wu MH; Hsiao W; Hsieh CL; Wu JS; Chao YS; Shih C; Wu SY; Ueng SH
Bioorg Med Chem Lett; 2014 Aug; 24(15):3403-6. PubMed ID: 24939758
[TBL] [Abstract][Full Text] [Related]
5. Marine natural products and other derivatives as potent indoleamine 2,3-dioxygenase inhibitors.
Delfourne E
Mini Rev Med Chem; 2012 Sep; 12(10):988-96. PubMed ID: 22512584
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of a novel library of antimitotic C
Chauhan J; Dasgupta M; Luthra T; Awasthi A; Tripathy S; Banerjee A; Paul S; Nag D; Chakrabarti S; Chakrabarti G; Sen S
Eur J Pharm Sci; 2018 Nov; 124():249-265. PubMed ID: 30170210
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel tryptoline derivatives as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Tanaka M; Li X; Hikawa H; Suzuki T; Tsutsumi K; Sato M; Takikawa O; Suzuki H; Yokoyama Y
Bioorg Med Chem; 2013 Mar; 21(5):1159-65. PubMed ID: 23337802
[TBL] [Abstract][Full Text] [Related]
8. Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
Dolušić E; Larrieu P; Blanc S; Sapunaric F; Pouyez J; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
Eur J Med Chem; 2011 Jul; 46(7):3058-65. PubMed ID: 21419531
[TBL] [Abstract][Full Text] [Related]
9. Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
Serra S; Moineaux L; Vancraeynest C; Masereel B; Wouters J; Pochet L; Frédérick R
Eur J Med Chem; 2014 Jul; 82():96-105. PubMed ID: 24878638
[TBL] [Abstract][Full Text] [Related]
10. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potent indoleamine 2,3-dioxygenase (IDO) inhibitor from alkaloids in Picrasma quassioides by virtual screening and in vitro evaluation.
Wang N; Zhang J; Li Q; Xu H; Chen G; Li Z; Liu D; Yang X
Fitoterapia; 2019 Mar; 133():137-145. PubMed ID: 30654128
[TBL] [Abstract][Full Text] [Related]
12. Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
Yang S; Li X; Hu F; Li Y; Yang Y; Yan J; Kuang C; Yang Q
J Med Chem; 2013 Nov; 56(21):8321-31. PubMed ID: 24099220
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate.
Crosignani S; Bingham P; Bottemanne P; Cannelle H; Cauwenberghs S; Cordonnier M; Dalvie D; Deroose F; Feng JL; Gomes B; Greasley S; Kaiser SE; Kraus M; Négrerie M; Maegley K; Miller N; Murray BW; Schneider M; Soloweij J; Stewart AE; Tumang J; Torti VR; Van Den Eynde B; Wythes M
J Med Chem; 2017 Dec; 60(23):9617-9629. PubMed ID: 29111717
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship and enzyme kinetic studies on 4-aryl-1H-1,2,3-triazoles as indoleamine 2,3-dioxygenase (IDO) inhibitors.
Huang Q; Zheng M; Yang S; Kuang C; Yu C; Yang Q
Eur J Med Chem; 2011 Nov; 46(11):5680-7. PubMed ID: 21925773
[TBL] [Abstract][Full Text] [Related]
15. Research progress of indoleamine 2,3-dioxygenase inhibitors.
Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy.
Yentz S; Smith D
BioDrugs; 2018 Aug; 32(4):311-317. PubMed ID: 29980987
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of the Reported Pyranonaphthoquinone Structure of the Indoleamine-2,3-dioxygenase Inhibitor Annulin B by Regioselective Diels-Alder Reaction.
Inman M; Carvalho C; Lewis W; Moody CJ
J Org Chem; 2016 Sep; 81(17):7924-30. PubMed ID: 27513176
[TBL] [Abstract][Full Text] [Related]
18. Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen.
Smith JR; Evans KJ; Wright A; Willows RD; Jamie JF; Griffith R
Bioorg Med Chem; 2012 Feb; 20(3):1354-63. PubMed ID: 22112538
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
20. 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.
Lin SY; Yeh TK; Song JS; Hung MS; Cheng MF; Liao FY; Li AS; Cheng SY; Lin LM; Chiu CH; Wu MH; Lin YJ; Hsiao W; Sun M; Wang YH; Huang CH; Tang YC; Chang HH; Huang ZT; Chao YS; Shih C; Pan SL; Wu SY; Kuo CC; Ueng SH
Bioorg Chem; 2018 Apr; 77():600-607. PubMed ID: 29494816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
